Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

ByScott D. Ramsey, MD, PhD,Gary H. Lyman, MD, MPH

April 16th 2015

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

BySuja S. Rajan, MHA, MS, PhD,William R. Carpenter, MHA, PhD,Sally C. Stearns, PhD,Gary H. Lyman, MD, MPH

February 13th 2013

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

Latest Updated Articles

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
April 16th 2015
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
February 13th 2013

Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Latest Updated Articles

Trending on AJMC

Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer

VBC Risk Is Outpacing Provider Readiness, CMS Must Act

FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion

Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment

Preparing Practices for the Next Era of Hepatitis B Care